Skip to main content

Balancing act: New developments and tensions in private sector access to DMPA-SC and self-injection

The Injectables Access Collaborative Learning and Action Network, in collaboration with USAID’s Frontier Health Markets Engage project, hosted this December 7, 2023 webinar on the latest innovations, policy developments, and evidence on access to DMPA-SC and self-injection through private sector channels such as pharmacies, drug shops, and private clinics.

One-third of contraceptive users in low- and middle-income countries access their method from a private sector source. Momentum is growing to ensure that contraceptive injectables, including DMPA-SC/self-injection, are among the range of methods offered through private channels. Speakers shared the latest evidence regarding pharmacy and drug shop provision of DMPA-SC/self-injection, updates on the release of a generic product, reflections on packaging for the private sector, and tensions between equity and financial sustainability in a changing landscape for contraceptive procurement financing. Speakers and participants discussed innovations to improve private sector channel economics and advance both equity and sustainability.